Fasudil May Interfere with Leukemia Cancer Cell Growth (IMAGE)
Caption
Mutations in several oncogenes activate Rho kinase (ROCK), which promotes abnormal growth of cancer cells and can lead to leukemia. Laboratory tests by a team lead by Indiana University School of Medicine scientists found that Fasudil, which targets ROCK, can inhibit the growth of the cancer cells.
Credit
Indiana University School of Medicine
Usage Restrictions
None
License
Licensed content